clinical trial · NCT07513207
A Study in Healthy People to Test How Vicadrostat Affects the Heart
HealthyVicadrostatPlacebo matching VicadrostatMoxifloxacin
brief summary
The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.
started
Apr 22, 2026
primary completion
Jul 24, 2026
completion
Aug 21, 2026
last updated
Apr 30, 2026
official title
Thorough QT Study to Evaluate the Effects of Single Doses of Vicadrostat on Cardiac Safety Parameters in Healthy Male and Female Subjects (a Randomized, Placebo-controlled, Double-blind, Five-period Crossover Study With Open-label Moxifloxacin as Positive Control)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol